Repository logo
 
Publication

Hepatitis C antibody prevalence and behavioral correlates in people who inject drugs attending harm reduction services in Lisbon, Portugal

2022-08-23Journal article Open access
Simple item page
dc.contributor.authorCurado, Adriana
dc.contributor.authorNogueira, Paulo Jorge
dc.contributor.authorVirgolino, Ana
dc.contributor.authorSanta Maria, João
dc.contributor.authorMendão, Luís
dc.contributor.authorFurtado, Cristina
dc.contributor.authorAntunes, Francisco
dc.date.accessioned2023-03-17T15:58:10Z
dc.date.available2023-03-17T15:58:10Z
dc.date.issued2022-08-23
dc.descriptionFree PMC article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445135/pt_PT
dc.description.abstractThe hepatitis C virus (HCV) infection is an important public health problem, affecting millions of people worldwide. People who inject drugs (PWID) are at increased risk of HCV infection due to, among other factors, widespread unsafe injecting practices, such as sharing of infected equipment or unprotected sexual practices. In Portugal, there is a lack of data regarding the proportion of infected persons through injecting drug use. This study aimed to evaluate the anti-HCV prevalence and behavioral correlates of infection in PWID attending harm reduction services in the Metropolitan Area of Lisbon, Portugal. A cross-sectional study with a purposive sample of PWID was undertaken between March 2018 and March 2020. Participants were recruited through the harm-reduction services of a nongovernmental organization. A rapid diagnostic test for anti-HCV screening was performed. Data on drug consumption history and current practices, past HCV testing, care and treatment history, and knowledge regarding hepatitis C were also collected through a questionnaire applied by trained inquirers. A total of 176 PWID participated in this study. An overall prevalence of 70.5% of anti-HCV positive in this population was found. Those with an anti-HCV positive testing result tended to start consuming at a younger age and have a higher consumption of benzodiazepines in the last 30 days. Sharing needles and other injecting material is a frequent risk behavior among this group. Also, they are more likely to have attended an opioid agonist treatment and to have undertaken previous hepatitis C and HIV tests in the past. This study represents an important effort to better understand the HCV prevalence and behavioral correlates of infection among PWID in Portugal, as well as to better estimate those in need of HCV treatment.pt_PT
dc.description.sponsorshipThis study was funded by Gillead Sciences Portugal (https:// www.gilead.com/utility/global-operations/europe/portugal/por tugal-translation) and Fundação para a Ciência e a Tecnologia (https://www.fct.pt/), grant numbers UIDB/04295/2020 and UIDP/04295/2020.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationFront Public Health. 2022 Aug 23;10:952909. doi: 10.3389/fpubh.2022.952909. eCollection 2022pt_PT
dc.identifier.doi10.3389/fpubh.2022.952909pt_PT
dc.identifier.issn2296-2565
dc.identifier.urihttp://hdl.handle.net/10400.18/8560
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherFrontiers Mediapt_PT
dc.relationEnvironmental Health Institute
dc.relationEnvironmental Health Institute
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fpubh.2022.952909/fullpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectHepatitis Cpt_PT
dc.subjectHepatitis C Viruspt_PT
dc.subjectBehavioral Correlates Of Infectionpt_PT
dc.subjectInjecting Drug Usept_PT
dc.subjectPrevalencept_PT
dc.subjectEpidemiologypt_PT
dc.subjectPortugalpt_PT
dc.subjectEstados de Saúde e de Doençapt_PT
dc.titleHepatitis C antibody prevalence and behavioral correlates in people who inject drugs attending harm reduction services in Lisbon, Portugalpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleEnvironmental Health Institute
oaire.awardTitleEnvironmental Health Institute
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04295%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04295%2F2020/PT
oaire.citation.startPage952909pt_PT
oaire.citation.titleFrontiers in Public Healthpt_PT
oaire.citation.volume10pt_PT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.embargofctAcesso de acordo com política editorial da revista.pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublication3b07eced-ff53-4cd9-94e3-064261672665
relation.isProjectOfPublication2932272c-f9a3-4271-90b9-39cbdc06e6c7
relation.isProjectOfPublication.latestForDiscovery3b07eced-ff53-4cd9-94e3-064261672665

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
fpubh-10-952909.pdf
Size:
272.84 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

DDI - Artigos em revistas internacionais